Company Filing History:
1 out of 366 
1 out of 18 
1 out of 832,880 Years Active: 1991-2011
Title: Innovations by Jean-Pierre Mach
Introduction
Jean-Pierre Mach is a notable inventor based in Lausanne, Switzerland. He has made significant contributions to the field of biomedical research, particularly in the development of pharmaceutical compositions that modulate immune responses. With a total of three patents to his name, Mach's work has the potential to impact various medical applications.
Latest Patents
One of Mach's latest patents is focused on compositions comprising fetal hemoglobin and bacterial endotoxin, along with additional fetal liver components. This invention presents a novel immunomodulating principle that surprisingly demonstrates a synergistic biomedical activity. The composition is designed to stimulate the immune system and can be delivered orally, making it applicable for treating allergic conditions, malignancies, chronic infections, autoimmune phenomena, and age-related imbalances.
Another significant patent involves carcino-embryonic antigen (CEA) derivatives that lack the carboxyl terminal end. This invention provides recombinant CEA glycoproteins that are antigenically indistinguishable from the soluble form of CEA shed from tumor cells. These glycoproteins can be utilized in immunoassays for diagnosing neoplastic diseases, showcasing Mach's innovative approach to cancer diagnostics.
Career Highlights
Jean-Pierre Mach has worked with prominent companies in the biomedical field, including Research Corporation Technologies, Inc. and Roche Diagnostic Systems, Inc. His experience in these organizations has contributed to his expertise and the development of his patented inventions.
Collaborations
Mach has collaborated with notable professionals in his field, including Franz Buchegger and Alexey Terskikh. These collaborations have likely enriched his research and innovation processes.
Conclusion
Jean-Pierre Mach's contributions to biomedical research through his patents highlight his innovative spirit and dedication to improving medical treatments. His work continues to pave the way for advancements in immunology and cancer diagnostics.